Travel Vaccines: A US and European Perspective

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

As the cost of travel has decreased, more and more people are choosing to travel abroad for business and leisure. As a result, they can be exposed to pathogens non-endemic to their countries of origin. Ensuring that patients are vaccinated to reduce the risk of infection while travelling is an important tenet of practicing travel medicine. This report covers the management of travel vaccinations in the US and Europe, focusing on travel habits of residents to high-risk areas, current and future travel vaccines, and research and development strategies.


GlobalData’s Travel Vaccines: A US and European Perspective combines key opinion leader insight with in-house analyst expertise and research to provide an insight-rich look at vaccination in US and European travelers.

Components of the report include:

• Overview of Travel-Associated Diseases – Which diseases are vaccinated against in travelers.

• Habits of US and European Travelers – Which travel destinations carry the greatest risk of diseases.

• Travel Vaccine Management – How is the prescription and reimbursement of travel vaccines handled across the US and Europe.

• Established Disease Markets for Travel Vaccines – What are the current and pipeline products available for diseases currently vaccinated against in travelers.

• Emerging Disease Markets for Travel Vaccines – What diseases may be vaccinated against in travelers in the future, and which products are in the pipeline.

• Research and Development Strategies – How are travel vaccine-relevant clinical trials being designed, and what is required for regulatory approval in the US and EU.

Reasons to Buy

Develop business strategies by understanding the trends shaping and driving the travel vaccine market in the US and Europe.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the portfolios of various competitors.

Identify areas of unmet need within the travel vaccines market to help drive research and development towards future market opportunities.

Gain insights to help plan and design your clinical trials.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Identify key pricing and reimbursement strategies.

Beijing Minhai Biotechnology
Boryung Pharmaceutical
Cadila Healthcare
China National Pharmaceutical Group
CPL Biologicals
Dynavax Technologies
Finlay Institute
International Vaccine Institute
Livzon Pharmaceutical Group
Merck & Co
Sanofi Pasteur
Shandong Hengye Biotech
The National Institute of Allergy and Infectious Diseases
VBI Vaccines
Wellcome Trust

Table of Contents

Table of Contents (PowerPoint Deck)

1. Preface

1.1 Related Reports

1.3 List of Abbreviations

2. Executive Summary

2.1 Key Findings

2.2 What KOLs Are Saying

3. Market Overview

3.1 Global Burden of Infectious and Parasitic Diseases

3.2 Key Infectious Diseases by Region

3.3 Annual Travelers from the US and Europe

3.4 Change in Yearly US Travelers Over Time

3.5 Top 10 US Travel Destinations

3.6 Top 10 European Travel Destinations

4. Travel Vaccine Management

4.1 Available Travel Vaccines

4.2 Where is Care Provided for Travel Vaccinations?

4.3 Travel Vaccine Reimbursement

4.4 Vaccination Records

4.5 Risk Factors when Travelling

4.6 Factors Affecting Successful Vaccination

5. Established Disease Markets for Travel Vaccines

5.1 Cholera

5.2 Hepatitis A

5.3 Hepatitis B

5.4 Japanese Encephalitis

5.5 Meningococcal Meningitis

5.6 Rabies

5.7 Typhoid Fever

5.8 Yellow Fever

6. Emerging Disease Markets for Travel Vaccines

6.1 Chikungunya

6.2 Dengue Fever

6.3 Malaria

6.4 Other Diseases with Unmet Need for Travel Vaccines

7. Research and Development Strategies

7.1 Travel-Vaccine-Relevant Clinical Trials

7.2 Top Travel-Vaccine-Relevant Indications

7.3 Different Classes of Pipeline Vaccines

7.4 Geographic Spread of Clinical Trials

7.5 Source of Sponsorship for Travel-Vaccine-Relevant Trials

7.6 Enrolment for Travel-Vaccine-Relevant Trials

8. Appendix

8.1 Bibliography

8.2 Primary Research

8.3 About the Authors

8.4 About GlobalData

8.5 Contact Us

8.6 Disclaimer

Frequently asked questions

Travel Vaccines: A US and European Perspective standard reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Travel Vaccines: A US and European Perspective was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Travel Vaccines: A US and European Perspective in real time.

  • Access a live Travel Vaccines: A US and European Perspective dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.